Literature DB >> 9477475

Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses.

A S Sheoran1, B T Sponseller, M A Holmes, J F Timoney.   

Abstract

Equine strangles, caused by the clonal pathogen Streptococcus equi, is a source of serious economic loss despite the widespread use of commercial vaccines. The anti-phagocytic 58 kDa M-like protein (SeM) is an important protective antigen. The objective of this study was to define differences, if any, between SeM-specific convalescent serum and mucosal IgA and IgG subisotypes and those induced by vaccination with commercial strangles vaccine. SeM-specific opsonophagocytic IgGb was the predominant serum antibody in horses intramuscularly vaccinated or recently recovered from infection. Infection also induced high levels of specific opsonophagocytic serum IgGa during and shortly after S. equi infection whereas vaccination stimulated only low levels of serum IgGa. Specific serum IgGc and opsonophagocytic IgA were present at very low levels following infection or vaccination. A strong specific mucosal antibody response occurred during the acute and convalescent phases of infection whereas vaccinated horses made no mucosal response. Specific IgGb was generally predominant in nasopharyngeal washings during the acute phase but was replaced by specific IgA during convalescence. SeM-specific mucosal IgGa and IgG(T) but not IgGc were detected only during the acute and early convalescent phase. The results therefore indicate that vaccination, although inducing SeM-specific serum isotype responses qualitatively and quantitatively similar to those seen in convalescence, did not induce mucosal responses. This suggests that mucosal immunity may be important in acquired resistance to strangles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9477475     DOI: 10.1016/s0165-2427(97)00074-3

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  11 in total

1.  Characterization and protective immunogenicity of the SzM protein of Streptococcus zooepidemicus NC78 from a clonal outbreak of equine respiratory disease.

Authors:  Sridhar Velineni; John F Timoney
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

2.  Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.

Authors:  Kathleen E Hooper-McGrevy; Bruce N Wilkie; John F Prescott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

3.  Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses.

Authors:  Margareta Flock; Karin Jacobsson; Lars Frykberg; Timothy R Hirst; Anders Franklin; Bengt Guss; Jan-Ingmar Flock
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees and rhesus macaques.

Authors:  H Craig Morton; Richard J Pleass; Anne K Storset; Per Brandtzaeg; Jenny M Woof
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

5.  IgA in the horse: cloning of equine polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA.

Authors:  M J Lewis; B Wagner; R M Irvine; J M Woof
Journal:  Mucosal Immunol       Date:  2010-07-14       Impact factor: 7.313

6.  Streptococcus equi Infections in Horses: Guidelines for Treatment, Control, and Prevention of Strangles-Revised Consensus Statement.

Authors:  A G Boyle; J F Timoney; J R Newton; M T Hines; A S Waller; B R Buchanan
Journal:  J Vet Intern Med       Date:  2018-02-09       Impact factor: 3.333

7.  Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival.

Authors:  Marcus Fulde; Manfred Rohde; Andy Polok; Klaus T Preissner; Gursharan Singh Chhatwal; Simone Bergmann
Journal:  MBio       Date:  2013-03-12       Impact factor: 7.867

8.  The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.

Authors:  Melanie J Lewis; Bettina Wagner; Jenny M Woof
Journal:  Mol Immunol       Date:  2007-07-31       Impact factor: 4.407

9.  A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system.

Authors:  Melanie J Lewis; Mary Meehan; Peter Owen; Jenny M Woof
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

10.  The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.

Authors:  Christine L Wimer; Christiane L Schnabel; Gillian Perkins; Susanna Babasyan; Heather Freer; Alison E Stout; Alicia Rollins; Nikolaus Osterrieder; Laura B Goodman; Amy Glaser; Bettina Wagner
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.